Cargando…
Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052926/ https://www.ncbi.nlm.nih.gov/pubmed/35045696 http://dx.doi.org/10.3324/haematol.2022.280619 |
_version_ | 1784696887371104256 |
---|---|
author | Attolico, Immacolata Tarantini, Francesco Carluccio, Paola Musto, Pellegrino |
author_facet | Attolico, Immacolata Tarantini, Francesco Carluccio, Paola Musto, Pellegrino |
author_sort | Attolico, Immacolata |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9052926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-90529262022-05-13 Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose Attolico, Immacolata Tarantini, Francesco Carluccio, Paola Musto, Pellegrino Haematologica Comments Fondazione Ferrata Storti 2022-01-20 /pmc/articles/PMC9052926/ /pubmed/35045696 http://dx.doi.org/10.3324/haematol.2022.280619 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Comments Attolico, Immacolata Tarantini, Francesco Carluccio, Paola Musto, Pellegrino Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title | Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title_full | Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title_fullStr | Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title_full_unstemmed | Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title_short | Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
title_sort | serological response following anti-sars-cov-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose |
topic | Comments |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052926/ https://www.ncbi.nlm.nih.gov/pubmed/35045696 http://dx.doi.org/10.3324/haematol.2022.280619 |
work_keys_str_mv | AT attolicoimmacolata serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose AT tarantinifrancesco serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose AT carlucciopaola serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose AT mustopellegrino serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose |